- Home
- GUG vs SIGA Comparison
GUG vs SIGA Comparison
Compare GUG & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GUG
- SIGA
- Stock Information
- Founded
- GUG 2021
- SIGA 1995
- Country
- GUG United States
- SIGA United States
- Employees
- GUG N/A
- SIGA N/A
- Industry
- GUG Trusts Except Educational Religious and Charitable
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- GUG Finance
- SIGA Health Care
- Exchange
- GUG Nasdaq
- SIGA Nasdaq
- Market Cap
- GUG 524.4M
- SIGA 594.3M
- IPO Year
- GUG N/A
- SIGA 1997
- Fundamental
- Price
- GUG $15.18
- SIGA $5.95
- Analyst Decision
- GUG
- SIGA
- Analyst Count
- GUG 0
- SIGA 0
- Target Price
- GUG N/A
- SIGA N/A
- AVG Volume (30 Days)
- GUG 108.9K
- SIGA 461.6K
- Earning Date
- GUG 01-01-0001
- SIGA 11-06-2025
- Dividend Yield
- GUG 9.67%
- SIGA 10.10%
- EPS Growth
- GUG N/A
- SIGA N/A
- EPS
- GUG N/A
- SIGA 1.03
- Revenue
- GUG N/A
- SIGA $172,249,641.00
- Revenue This Year
- GUG N/A
- SIGA N/A
- Revenue Next Year
- GUG N/A
- SIGA $115.06
- P/E Ratio
- GUG N/A
- SIGA $5.77
- Revenue Growth
- GUG N/A
- SIGA N/A
- 52 Week Low
- GUG $12.71
- SIGA $4.95
- 52 Week High
- GUG $15.06
- SIGA $9.62
- Technical
- Relative Strength Index (RSI)
- GUG 42.57
- SIGA 26.58
- Support Level
- GUG $14.93
- SIGA $5.71
- Resistance Level
- GUG $15.51
- SIGA $6.05
- Average True Range (ATR)
- GUG 0.24
- SIGA 0.32
- MACD
- GUG -0.02
- SIGA -0.07
- Stochastic Oscillator
- GUG 35.52
- SIGA 8.91
About GUG Guggenheim Active Allocation Fund of Beneficial Interest
Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.